Your session is about to expire
← Back to Search
CGM + Behavioral Intervention for Type 2 Diabetes
Study Summary
This trial will test if using CGM & text-based behavior changes can improve glycemic regulation & diabetes distress in adults w/type 2 diabetes.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently receiving dialysis.I do not speak English.I am 45 years old or older.I have been diagnosed with type 2 diabetes.I can walk and have never been told by a doctor that it's unsafe for me to do low-intensity walking.You have high levels of stress related to your diabetes.
- Group 1: CGM paired with behavior change technique interventions, mood intervention first
- Group 2: CGM paired with behavior change technique interventions, physical activity intervention first
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you provide an estimate of the available vacancies for this research endeavor?
"According to the clinicaltrials.gov portal, this study is no longer recruiting patients and has not done so since July 7th 2023. However, there are numerous other ongoing trials that require participants at the present moment - 1459 in total!"
What is the primary goal of this clinical trial?
"This clinical trial will assess a primary outcome, Diabetes Distress, and three secondary outcomes: the Summary of Diabetes Self-Care Activities Scale (SDSCA), Patient Health Questionnaire-8, and two subscales from the Health Problem-Solving Scale. During the 10 week study period these results will be continuously monitored for an Average Time in Range over both baseline/run-in 2 weeks as well as during 8 weeks of intervention. Responses range on a scale from 0 to 7 days with higher scores indicating more frequent engagement in behavior or greater depressive symptom severity; while responses for HPS Avoidant and Impulsive/Careless Sub"
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger